The Intrahepatic Expression and Distribution of BTLA and its Ligand HVEM in patients with HBV-related acute-on-chronic liver failure

详细信息查看全文

作者：Huan Xu (1) (2) Dayan Cao (1) (2) Guoning Guo (3) Zhihua Ruan (4) Yuzhang Wu (2) Yongwen Chen (1) (2)
关键词：BTLA ; HBV ; ACLF ; HVEM ; Immunohistochemistry ; B7 superfamily
刊名：Diagnostic Pathology
出版年：2012
出版时间：December 2012
年：2012
卷：7
期：1
全文大小：1250KB
参考文献：1. Stravitz RT, Kramer DJ: Management of acute liver failure. / Nat Rev Gastroenterol Hepatol 2009, 6:542鈥?53. CrossRef 2. Liu Q, Liu Z, Wang T, / et al.: Characteristics of acute and sub-acute liver failure in China: nomination, classification and interval. / J Gastroen Hepatol 2007, 22:2101鈥?106. CrossRef 3. Liu M, Chan C, McGilvray I, / et al.: Fulminant viral hepatitis: molecular and cellular basis, and clinical implications. / Expert Rev Mol Med 2001, 2001:1鈥?9. 4. Marsden PA, Ning Q, Fung L, / et al.: The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis. / J Clin Invest 2003, 112:58鈥?6. 5. Watanabe N, Gavrieli M, Sedy JR, / et al.: BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1. / Nat Immuno 2003, 4:670鈥?79. CrossRef 6. Deppong C, Juehne TI, Hurchla M, / et al.: Cutting edge: B and T lymphocyte attenuator and programmed death receptor-1 inhibitory receptors are required for termination of acute allergic airway inflammation. / J Immunol 2006, 176:3909鈥?913. 7. Oya Y, Watanabe N, Owada T, / et al.: Development of autoimmune hepatitis-like disease and production of autoantibodies to nuclear antigens in mice lacking B and T lymphocyte attenuator. / Arthritis Rheum 2008, 58:2498鈥?510. CrossRef 8. Tao R, Wang L, Han R, / et al.: Differential effects of B and T lymphocyte attenuator and programmed death-1 on acceptance of partially versus fully MHC-mismatched cardiac allografts. / J Immunol 2005, 175:5774鈥?782. 9. Serriari NE, Gondois-Rey F, Guillaume Y, / et al.: B and T lymphocyte attenuator is highly expressed on CMV-specific T cells during infection and regulates their function. / J Immunol 2010, 185:3140鈥?148. CrossRef 10. Sun Y, Brown NK, Ruddy MJ, / et al.: B and T lymphocyte attenuator tempers early infection immunity. / J Immunol 2009, 183:1946鈥?951. CrossRef 11. Sedy JR, Gavrieli M, Potter KG, / et al.: B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator. / Nat Immunol 2005, 6:90鈥?8. CrossRef 12. Gavrieli M, Watanabe N, Loftin SK, / et al.: Characterization of phosphotyrosine binding motifs in the cytoplasmic domain of B and T lymphocyte attenuator required for association with protein tyrosine phosphatases SHP-1 and SHP-2. / Biochem Biophys Res Commun 2003, 312:1236鈥?243. bbrc.2003.11.070">CrossRef 13. Yang C, Chen Y, Guo G, / et al.: Expression of B and T lymphocyte attenuator (BTLA) in macrophages contributes to the fulminant hepatitis caused by murine hepatitis virus strain-3. / Gut 2012. Jun 9. [Epub ahead of print] 14. Cao D, Xu H, Guo G, / et al.: Intrahepatic Expression of Programmed Death-1 and its Ligands in Patients with HBV-Related Acute-on-Chronic Liver Failure. / Inflammation 2012. Aug 16. [Epub ahead of print] 15. Guo G, Cao D, Xu H, / et al.: The characteristic expression of B7-H3 and B7-H4 in liver biopsies from patients with HBV-related acute-on-chronic liver failure. / Pathology Int 2012, 62:665鈥?74. CrossRef 16. Murphy TL, Murphy KM: Slow down and survive: Enigmatic immunoregulation by BTLA and HVEM. / Annu Rev Immunol 2010, 28:389鈥?11. CrossRef 17. Derr茅 L, Rivals JP, Jandus C, / et al.: BTLA mediates inhibition of human tumor-specific CD8+ T cells that can be partially reversed by vaccination. / J Clin Invest 2010, 120:157鈥?67. CrossRef 18. Pasero C, Speiser DE, Derr茅 L, / et al.: The HVEM network: new directions in targeting novel costimulatory/co-inhibitory molecules for cancer therapy. / Curr Opin Pharmacol 2012, 12:478鈥?85. CrossRef 19. Nascimento C, Bottino A, Nogueira C, / et al.: Analysis of morphological variables and arterialization in the differential diagnosis of hepatic nodules in explanted cirrhotic livers. / Diagn Pathol 2007, 2:51. CrossRef 20. Das P, Jain D, Das A: A retrospective autopsy study of histopathologic spectrum and etiologic trend of fulminant hepatic failure from north India. / Diagn Pathol 2007, 2:27. CrossRef 21. Dong H, Zhu G, Tamada K, / et al.: B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. / Nat Med 1999, 5:1365鈥?369. CrossRef 22. Latchman Y, Wood CR, Chernova T, / et al.: PD-L2 is a second ligand for PD-1 and inhibits T cell activation. / Nat Immuno 2001, 2:261鈥?68. CrossRef 23. Chapoval AI, Ni J, Lau JS, / et al.: B7-H3: A costimulatory molecule for T cell activation and IFN-gamma production. / Nat Immunol 2001, 2:269鈥?74. CrossRef 24. Hashiguchi M, Kobori H, Ritprajak P, / et al.: Triggering receptor expressed on myeloid cell-like transcript 2 (TLT-2) is a counterreceptor for B7-H3 and enhances T cell responses. / Proc Natl Acad Sci USA 2008, 105:10495鈥?0500. CrossRef 25. Sica GL, Choi IH, Zhu G, / et al.: B7-H4, a molecule of the B7 family, negatively regulates T cell immunity. / Immunity 2003, 18:849鈥?61. CrossRef 26. Prasad DV, Richards S, Mai XM, / et al.: B7S1, a novel B7 family member that negatively regulates T cell activation. / Immunity 2003, 18:863鈥?73. CrossRef 27. Suh WK, Wang S, Duncan GS, / et al.: Generation and characterization of B7-H4/B7S1/B7x-deficient mice. / Mol Cell Biol 2006, 26:6403鈥?411. CrossRef 28. Zhu G, Augustine MM, Azuma T, / et al.: B7-H4-deficient mice display augmented neutrophil-mediated innate immunity. / Blood 2009, 113:1759鈥?767. blood-2008-01-133223">CrossRef
作者单位：Huan Xu (1) (2) Dayan Cao (1) (2) Guoning Guo (3) Zhihua Ruan (4) Yuzhang Wu (2) Yongwen Chen (1) (2) 1. Institute of Immunology, PLA, Third Military Medical University, Chongqing, 400038, People鈥檚 Republic of China 2. Undergraduate Administration Office, Third Military Medical University, Chongqing, 400038, People鈥檚 Republic of China 3. Department of Emergency, South-West Hospital, PLA, Third Military Medical University, Chongqing, 400038, People鈥檚 Republic of China 4. Department of Oncology, South-West Hospital, PLA, Third Military Medical University, Chongqing, 400038, People鈥檚 Republic of China

文摘

Objective It has been demonstrated that signals from the inhibitory receptor B and T lymphocyte attenuator (BTLA) are involved in regulating the pathogenesis of infectious diseases. However, the expression and anatomical distribution of BTLA and its ligand, the herpes virus entry mediator (HVEM), have not yet been determined in cases of HBV-related acute-on-chronic liver failure (HBV-ACLF) patients. Methods In this study, the expression of BTLA and HVEM in liver tissues from HBV-ACLF, chronic hepatitis B (CHB) patients and healthy individuals was analyzed by immunohistochemistry. Results The results of this analysis demonstrated that both molecules were observed in the HBV-ACLF samples and that their expression was chiefly in the infiltrating inflammatory cells and the damaged bile ducts. However, they were absent in liver sections from CHB patients and healthy controls. Immunofluorescence double-staining indicated that BTLA was found on CK-18+ epithelial cells, CD31+ endothelial cells, CD68+ macrophages, CD56+ NK cells, CD16+ monocytes, CD3+ , CD8+ T cells, and Foxp3+ regulatory T cells (Treg). By contrast, HVEM expression was restricted to CK18+ epithelial cells and CD68+ macrophages. Moreover, the expression of several members of the B7 superfamily, including PD-L1, PD-L2, B7-H3 and B7-H4, was also detected in these liver tissues, and these proteins were co-expressed with HVEM. Interestingly, the expression of fibrinogen-like protein 2 (FGL2), a virus-induced procoagulant molecule, was also found in liver sections from HBV-ACLF, this molecule also co-expresses with BTLA and HVEM. Conclusions These results suggest that BTLA-HVEM signaling is likely to affect the pathogenesis of HBV-ACLF, a clear understanding of the functional roles of these proteins should further elucidate the disease process. Virtual slides The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/8080806838149123

地址：北京市海淀区学院路29号邮编：100083

电话：办公室：(+86 10)66554848；文献借阅、咨询服务、科技查新：66554700